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Background: Cardiovascular disease (CVD) is the most costly disease in Australia. Measuring the impact of ageing
on its costs is needed for planning future healthcare budget. The aim of this study was to measure the impact of
changes in population age structure in Western Australia (WA) on the costs of hospitalisation for CVD.
Methods: All hospitalisation records for CVD occurring in WA in 1993/94 and 2003/04 inclusive were extracted
from the WA Hospital Morbidity Data System (HMDS) via the WA Data Linkage System. Inflation adjusted
hospitalisation costs using 2012 as the base year was assigned to all episodes of care using Australian Refined
Diagnosis Related Group (AR-DRG) costing information. The component decomposition method was used to
measure the contribution of ageing and other factors to the increase of hospitalisation costs for CVD.
Results: Between 1993/94 and 2003/04, population ageing contributed 23% and 30% respectively of the increase
in CVD hospitalisation costs for men and women. The impact of ageing on hospitalisation costs was far greater for
chronic conditions than acute coronary syndrome (ACS) and stroke.
Conclusions: Given the impact of ageing on hospitalisation costs, and the disparity between chronic and acute
conditions, disease-specific factors should be considered in planning for future healthcare expenditure.
Keywords: Cardiovascular disease, Health expenditures, Population ageing, Data linkageBackground
The population in developed countries is ageing as a
result of the increase in life expectancy and low fertility
[1]. It is generally agreed that these ageing populations
will cause a considerable socioeconomic impact for the
community as a whole and healthcare systems in particu-
lar [2]. However, an explanation for the link between
healthcare expenditure and ageing is still a ‘black box’ [1].
To guide health policy, it is important to examine closely
the influence of ageing on healthcare expenditure within a
particular country.
In Australia, the proportion of those aged 65 years and
older has increased from 11.1% in 1990 to 13.6% in 2010
[3]. It is projected that the proportion will increase to
16% by 2016 and 25% by 2051 [2]. Simultaneously, over* Correspondence: ninh.ha05@gmail.com
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unless otherwise stated.the past decade, healthcare expenditure has increased at
a rate higher than that of other goods and services [4].
The age-expenditure profile shows that higher costs are
spent on the older population, for example, expenditure
on healthcare for those aged 65 years and older was four
times higher than those under 65 years [2,5]. Coupled
with this, the life span living with disability has also
been found to be increasing in many studies [6,7]. Due to
this expansion in morbidity, the demand for healthcare
services is likely to increase, in turn escalating healthcare
expenditure [2,8].
While the relationship between ageing and healthcare
expenditure in Australian and other developed countries
has been examined in the literature [1,5,9-12], there is a
discordance regarding the magnitude of the impact of
ageing on healthcare expenditure. For instance, studies in
France have found that only 3.4% of the rise in healthcare
expenditure was attributable to ageing while in Korea it was
approximately 10% [9,13]. In contrast, a study in AustraliaThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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to almost 50% of the increase in healthcare expenditure
between 2002/03 and 2044/45 [5]. Although those studies
examined the impact of ageing on healthcare expenditure,
each study were focused on different type of expenditure.
The study in France were looked at a combination of
ambulatory, pharmaceutical and hospitalisation costs
while costs of health insurance in Korean, and govern-
ment healthcare expenditure in Australia were exam-
ined. Country specific factors may be the cause of
differences in the impact of ageing on healthcare ex-
penditure [14,15].
Currently, cardiovascular disease (CVD) is a leading
cause of death in Australia and the most costly disease,
accounting for 11% of total healthcare expenditure in
2005/06 [16], with hospital services comprising the
largest component of CVD total expenditure [17]. Ageing
is an unmodifiable risk factor of all disease, including CVD.
Thus, the ageing population may cause a considerable
burden for costs of CVD. However, there is limited
literature about the impact of the ageing population
on the costs of CVD-related hospitalisation. Considering
the rise in healthcare costs and the relative burden of
CVD, an understanding of the magnitude of the impact of
ageing on costs of treatment for CVD in Western Australia
(WA) will provide a useful evidence base for planning and
budgetary purposes and future policy formulation. The
aim of the study was to measure the contribution of
population ageing to the hospitalisation costs for CVD in
WA, using the component decomposition method. Through
the method, the hospitalisation costs were decomposed
into subcomponents and subsequently costs attributable
to ageing of the population in each component over a
period of time were isolated.
Methods
Study population and data source
All hospitalisations occurring in Western Australia
pertaining to patients aged 18 years and older with a
principal or co-diagnosis CVD code from 1 July 1993
to 30 June 2004 were extracted from the Hospital
Morbidity Data System (HMDS) using the Western
Australian Data Linkage System (WADLS) described
elsewhere [18,19]. The HMDC captures records of separa-
tions from all public, private acute care and psychiatric
hospitals and private freestanding day hospital facilities
in Western Australia [20]. The relevant CVD codes of
hospitalisations were identified using the International
Classification of Disease (ICD) codes version current at
the time of separation from hospital and are detailed in
the following sub section. Prior to data extraction, ethics
approval for this study was obtained from the Human
Research Ethics Committee at the University of Western
Australia and Curtin University.Case selection and classification
Common types of CVD in Australia were included in this
study. Relevant ICD codes to identify hospitalisations with
CVD were obtained from publications produced by the
Australian Institute of Health and Welfare (AIHW [17] and
L Nedkoff, TG Briffa, DB Preen, FM Sanfilippo, J Hung, SC
Ridout, M Knuiman and M Hobbs [21]. Events were
defined as CVD when they were recorded as either heart
failure, or angina pectoris, or acute myocardial infarction,
or unstable angina or stroke. All records were subsequently
grouped into three subgroups, namely chronic conditions
(ICD 9_CM 428, and 413, ICD 10-AM I50, and I20),
acute coronary syndromes (ACS) (ICD 9_CM 410, and
411.1, ICD 10-AM I21, and I20.0) and stroke (ICD 9_CM
430–432 and 436, ICD 10-AM I60-I64).
The individual records of hospitalisation were aggregated
into episodes of care, defined as a period of continuous
hospitalisation. Inter-hospital transfers were periods of in-
patient hospitalisation that overlapped with each other or
where separation (discharge) and admission dates were on
sequential days. Capture of transfers between hospitals is
required in order to avoid over counting of the number of
hospitalisation events. In our study periods of contiguous
in-patient hospitalisation were classified as episodes of care.
The episode of care was assigned to one of 17 age groups
(18–19, 20–24 to 90–94 in five-year age groups and 95+
years) determined by the age in years at admission time
of each individual. The first age group comprised only
two years (18–19 years) since data extraction was re-
stricted to hospitalisation records for individuals from
18 years and over.
Assigning cost to episodes of care
The Australian Refined Diagnosis Related Group is an
Australian admitted patient classification system, which
provides a way of relating the number and type of patients
treated in a hospital to the resources required by the
hospital. Acute admitted patient episodes of care are
categorised into groups with similar conditions and similar
usage of hospital resources, using information in the
hospital morbidity record such as the diagnoses, procedures
and demographic characteristics of patient.
The cost of each episode of care was assigned based
on AR-DRG code recorded in the HMDS record for
each record of hospitalisation included within an episode
of care (where there were inter-hospital transfers). The
cost attributed to each AR-DRG was that reported for
that AR-DRG in the National Hospital Cost Data Collection
Report relevant to the year of each separation [22]. The
cost was assigned inclusive for all hospitalisation events in
database before adjusting for the inter-hospital transfers
and therefore included multiple records in the case of
inter-hospital transfer. Thus, the costs of the inter-hospital
transfer episodes were a sum of any records which formed
Ha et al. BMC Health Services Research 2014, 14:554 Page 3 of 7
http://www.biomedcentral.com/1472-6963/14/554the episode of care. The hospitalisation costs included medi-
cations, investigation undertaken whole admitted, physicians,
nursing staff, operating theatre, emergency department and
“hotel” costs but not included rehabilitation costs. All dollar
values were adjusted to 2012 price levels, using health price
indices calculated from the Health and Welfare expenditure
series of the AIHW [23,24].
Statistical analysis
The total number of episodes (E) and cost per episode
(CPE) were calculated in five-year age groups by sex and
diagnosis subgroup at two points of time, 1993/94 and
2003/04. Number of episodes per capita (NEC) for gender
x and age-specific group j was calculated separately for
chronic conditions, ACS, stroke and overall CVD:
NECxj ¼ Ex;jPx;j , where Ex,j is the number episodes for
gender x and age-specific group j; Px,j is the WA population
in gender x and age group j for that year (obtained from the
Australian Bureau of Statistic Time Series Workbook
Table 55 (ABS 3101.0)) as the denominator [25]. The rates
were calculated per 100,000 population.
The cost per episode (CPE) for gender x and age specific
group j was calculated for chronic conditions, ACS, stroke
and overall CVD as following: CPE ¼ Cx;jEx;j , where Cx,j is
total cost in gender x and age group j; Ex,j is the number
of episodes in gender x and age group j.
In our study, the impact of population ageing on the
hospitalisation costs for CVD was measured using the
method that was adapted from the principles of the com-
ponent decomposition method used in studies in Australia
and Korea [12,13]. The previous studies, the change in
healthcare expenditure was attributable to the impact of
ageing, the growth of population over time, change in pro-
portion of people using healthcare services and change in
average cost per episode [12,13]. Similar to the studies, the
change in total costs of hospitalisation for CVD over a
period of time were attributable to following components:
population growth, ageing of the population, the increase
in total number of episodes of hospitalisations and the
increase in average cost per episode. Steps to calculate
proportion of contribution of each component to the
change in total costs of hospitalisation for CVD between
1993/94 and 2004/05 were described in detail below.
The total costs of hospitalisations for disease d in each
year was decomposed by the following equation:
Total hospitalisation costsd ¼P
WA populationj  number of episode per capitad;j 
cost per episoded;j ; where j denotes five−year age groups
ð1Þ
From equation (1), the change in the WA population
over the study period can be decomposed into a changein the total population and a change in the age distribu-
tion of population. Similarly, the change in the number of
hospital episodes per capita can be decomposed into a
change in the total number of episodes and a change in
the age distribution of episodes. Thus, a difference in the
total hospitalisation costs between 1993/94 and 2003/04
(DHC) was attributable to the change in total population
(CPOP), the change in the age distribution of population
(CDEM1), the change in the total number of episodes
(CTNE), the change in the age distribution of episodes
(CDEM2) and a change in cost per episode (CCPE).
A change in total hospitalisation costs for a disease d
for the time period t (1993/93 and 2003/04) was
DHCd ¼ CPOPd þ CDEM1d þ CDEM2d
þ CTNEd þ CCPEd
The total of changes attributable to the change in
the age structure of the population (CDEM1d) and to
the distribution of hospitalisation between age groups
CDEM2d reflect the impact of ageing on total costs, thus
impact of ageing = CDEM1d +CDEM2d. Through this
analysis the impact of the ageing of the population on the
cost of hospitalisation for CVD was isolated from the re-
spective costs of the increase in the general population
and the total number of hospitalisations.
In order to calculate the proportion of contribution of
each component, an age-specific cost profile, represents
the per capita healthcare cost of a specific age group, was
applied [26]. By holding age-specific cost profiles constant,
this approach has an assumption that the impact of other
variables with potential influence on healthcare cost does
not change [26]. Although the assumption is unrealistic, it
is useful for the purpose of isolating the impact of
demographic changes (ageing population). The method
has been used in many studies [12,26,27].
In our study, to capture the proportion of each com-
ponent contributing to the difference in total cost of
hospitalisation in the period, each component in initial
year (1993/94) was moved to actual value in 2003/04 in
sequence. As each component in the assumption was chan-
ged, the difference in total cost of hospitalisation between
initial year (1993/94) and the assumed final year (2003/04)
was attributable to whichever component was affected by
the change in assumption. Each assumption using the actual
value in 2003/04, the sum of the change in individual com-
ponents is equal to the change in total cost between the two
points of time. Details of the calculations are presented in
Additional file 1.
While it is common practice that sensitivity analysis is
conducted on health economic analyses to evaluate the
effect of various assumptions and the averaging of values
have on the magnitude of the final outcome, in this study
there were no assumptions made since the data were not
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were those recorded directly in the data set. Thus there
were no values that could be varied for use in a sensitivity
analysis. Descriptive analysis was conducted using SPSS
version 18. Calculations for the decomposition analysis
were done in Microsoft Excel 2010.
Results
The dataset consisted of 25,126 episodes of care for any
discharged diagnosis with CVD reported in the WADLS
in 1993/94 and 2003/04, of which almost 90% were for
chronic conditions and ACS and only 11.7% for stroke
(Table 1). Patients admitted for chronic conditions tended
to be older, and those admitted with ACS younger, than
the mean age across all CVD patients of 70.3 years
(SD 12.9 years) in 1993/94 and to 69.7 years (SD
13.8 years) in 2003/04. The proportion of men was higher
than women in all hospitalisations for CVD and subgroups.
Compared with 1993/94, the number of episode per
100,000 population and mean cost per episode in 2003/04
were higher for CVD and all subgroups (Table 1).
The results of the component decomposition analysis are
presented in Figure 1. For overall CVD, the contribution of
population ageing to the increase in the total cost of
hospitalisation was 22.9% in men and 22.7% in women. If
only total population had grown, but the age distribution
remained constant as in 1993/94, the total costs of hospi-
talisation for CVD would have increased by 21.5% in menTable 1 Characteristics of hospitalisations for cardiovascular
CVD Chronic con
Total episodes 25,126 (100.0) 11,334 (45.1
1993/94 10,592 (100.0) 4,645 (43.9)
2003/04 14,534 (100.0) 6,689 (46.0)
Age (mean (SD))
1993/94 70.3 (12.9) 73.2 (12.5)
2003/04 69.7 (13.8) 71.3 (13.4)
Sex
1993/94
Men 6,064 (57.3) 2,354 (50.7)
Women 4,528 (42.7) 2,291 (49.3)
2003/04
Men 8,760 (60.3) 3,991 (59.7)
Women 5,774 (39.7) 2,698 (40.3)
Number of episode per capita (per 100,000)
1993/94 852.6 373.9
2003/04 972.4 447.5
Mean cost per episode (A$)
1993/94 6,013.5 (4,134.4) 5,280.7 (2,44
2003/04 8,040.3 (8,957.9) 6,428.8 (7,00and 30.1% in women. More than half of the increase the
total hospitalisation costs was attributable to the increase
in average cost per episode. In contrast, if only the change
in the number of episodes was considered, total cost would
have reduced by 12.6% in women and increased by only
2.7% in men.
As shown in Figure 1, the contribution of the ageing
population to the increase in the total costs of hospital-
isation varied according to the subgroups, especially
among women. For chronic conditions, ageing of the
population accounted for over 50% of the rise in total
costs among women, but only 23.5% in women with
ACS and 1.7% in women with stroke. If only the change
in the mean cost per episode was taken into account,
this component would contribute to nearly 50% of the
rise in the total costs of hospitalisation for chronic con-
ditions and ACS in both men and women. In contrast,
the change in the mean cost per episode accounted for
96.2% and 70.9% in men and women respectively of the
increase in the total costs of hospitalisation for stroke.
The contribution of the ageing population to the rise
in the total costs of hospitalisation distinctly differed
between men and women (Figure 1). For example, the
contribution of ageing to the rise of the total costs of
hospitalisation was almost three times higher in women
than men for chronic conditions, 53.9% compared with
19.1%. In contrast, the impact of the ageing population
on the costs of hospitalisation for stroke was far greaterdisease and subgroups
ditions ACS Stroke
) 10,845 (43.5) 2,947 (11.7)
4,669 (44.1) 1,278 (12.1)
6,176 (42.5) 1,669 (11.5)
67.4 (12.9) 69.9 (12.2)
67.8 (13.6) 70.5 (15.2)
2,903 (62.2) 807 (63.1)
1,766 (37.8) 471 (36.9)
3,927 (63.6) 842 (50.4)
2,249 (36.4) 827 (49.6)
375.8 102.9
413.2 111.7
1.1) 6,482.8 (5,126.7) 6,962.8 (4,512.5)
2.4) 8,548.1 (8,276.1) 12,619.4 (14,718.5)
Figure 1 Decomposition of increasing total costs of hospitalisation for CVD and sub-groups by components among men and women
in 1993/94 to 2003/04.
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had a higher impact on the rise of total cost for chronic
conditions compared with ACS and stroke and the im-
pact was different between men and women.
Discussion
This study has examined the impact of ageing on the in-
crease in hospitalisation costs for CVD and subgroups
using the component decomposition method. The impact
of ageing was separated out from other components in-
cluding population growth, growth in the number of hos-
pitalisations and the increase in mean cost per episode.
The study showed that between 1993/94 and 2003/04 age-
ing contributed a considerable proportion to the increase
in hospitalisation costs for CVD, 22.9% in men and 30% in
women, although it was not the major component. The
impact of ageing also varied across CVD conditions and
was much higher for chronic conditions than acute condi-
tions (ACS and stroke).
The findings of this study are consistent with other
studies’ findings that ageing has an impact on healthcareexpenditure but is not a major contributor [9,13,28]. How-
ever, in other studies the impact of ageing was found to be
lower (less than 10%) [13,28]. The differences in the mag-
nitude of impact could be due to differences in the type of
expenditure. Other studies were conducted in the US and
were based on Medicare fees [28], and in Korea using
health insurance expenditure [13], and included a wide
range of diseases. This study focused on CVD hospitalisa-
tion costs, which constitute the largest share of CVD costs
in Australia, and ageing is a major risk factor for CVD
[29,30]. The result of the study may imply that a higher
impact of ageing population on CVD costs than general
healthcare expenditure. The findings are also in agreement
with other studies about the impact of ageing in Australia
[6,7]. Although these other studies did not directly meas-
ure the magnitude of the change in the age structure on
the hospitalisation costs for CVD, their results implied a
potential burden of healthcare services due to ageing.
Lynch, Holman and Moorin [7] found that the average
age for first time hospitalisations declined over the period
between 1980 and 2003, together with an increase in life
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ditions increased, inducing higher demand and cost for
healthcare.
Although the impact of ageing on healthcare expenditure
has been measured in many studies, little is known about
gender disparity [10,13,31]. Our results show a higher im-
pact of ageing on hospitalisation costs for CVD in women
than in men. This is explained by the finding that lifetime
healthcare expenditure in women was higher than in men
[32,33]. It is also a consequence of a higher life expectancy
and higher prevalence of chronic disease among women
compared with men [31].
Of interest is that the magnitude of the impact of ageing
on hospitalisation costs varied widely between subgroups
in women. Ageing was a main driver of the rise in the total
cost of hospitalisation for chronic conditions, but not for
ACS and stroke. For ACS and stroke, the main driver of
the rise in total costs of hospitalisation was the growth in
average cost per hospitalisation. This result is consistent
with a cross sectional study conducted on stroke, which
found that ageing had a relatively small impact on health-
care expenditure [34]. The strong effect of ageing on the
cost of hospitalisations for chronic conditions may reflect
the expansion of morbidity associated with chronic dis-
ease in Australia [7]. Coupled with this, the mortality rate
for heart failure, a main component of chronic conditions,
was found to have declined in patients aged 75 years and
older between 1997 and 2003 [35]. In addition, the pro-
portion of people aged 65 years and older increased while
the younger age groups remained stable [3]. All these fac-
tors may help explain the higher impact of ageing on hos-
pitalisation costs for chronic conditions. In Australia, the
“baby boomers” population cohort, who was born in the
20-year period after World War II, would have been
reaching middle age in this study period between 1990
and 2004. As these results only reflect the impact of age-
ing before the period of the baby boomer cohort reaching
older age, it is likely that the impact of ageing on
hospitalization costs for chronic conditions may accel-
erate in coming years.
Strengths and limitations of this study
The study used a validated and well respected source of
data and linkage mechanism which has been shown to
produce accurate (99% accuracy) individual level linked
data [18]. The data included all hospitalisation occurring
in the state (both private public and private) providing
highly generalizable population level information. Thus,
bias due to selection or sampling error is not present in
this study, leading to an increase in study power due to
the comprehensive population coverage. For the decom-
position of the increase in healthcare costs, although
major components contributing to the increase in total
costs of hospitalisation were taken into account, thecomponents could have been be broken down into more
detail. Average cost per hospitalisation, for example, can
be separated into number and type of services used within
each episode and cost per service. However, the available
costing data in the Hospital Morbidity Data System were
not sufficient to allow further decomposition. Since the
focus of the study was to evaluate the contribution of the
ageing component to CVD hospitalisation costs, this limi-
tation did not affect our ability to fulfil this aim. Another
limitation is that the time period for the analysis was
1993/94 to 2003/04. Since 2004, many changes in medical
management and advances in diagnosis have taken place.
Nevertheless, the findings of this study on the impact of
ageing on the costs of hospitalisation for CVD and sub-
groups provides a useful basis for projecting correspond-
ing costs in future time periods. Despite its limitations,
the study has shown the extent to which ageing has im-
pacted on costs of hospitalisation for CVD.
Conclusions
This study has demonstrated that population ageing was
a considerable factor, contributing to more than 20% of the
rise in the total hospitalisation costs for CVD. The magni-
tude of the impact of ageing varied across CVD conditions,
particularly among women. It was the main driver in the
rise of total hospitalisation costs for chronic condition in
women but only a minor factor for ACS and stroke. These
results suggest that disease-specific factors should be con-
sidered when measuring the impact of ageing on health-
care expenditure and planning for healthcare budgets,
as the magnitude of the impact was different between
acute and chronic conditions. Additional studies using
current data are needed to evaluate the impact of more
recent technological/clinical advancement on hospital-
isation costs of CVD.
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